GlassScriptPhysician profile
Bret C Musser
NPI 1801201579
$18,423.69
in general payments reported to CMS, 2019-2025
23 companies · $272 in 2025
The $272 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,244 · 2020: $1,634 · 2021: $1,683 · 2022: $4,967 · 2023: $4,224 · 2024: $2,399 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,927 · Travel and Lodging: $2,969.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,927.11 |
| Travel and Lodging | $2,968.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $15,191.86 | 2019-2025 | Ortholoc 2 Lapifuse, Inbone, Ortholoc 3di |
| Mvp Orthopedics INC | $1,497.78 | 2021-2022 | |
| Kerecis Limited | $546.16 | 2019-2021 | |
| Osteomed LLC | $319.61 | 2019-2022 | |
| Abbott Laboratories | $159.74 | 2024 | Proclaim |
| Mimedx Group, INC. | $130.73 | 2024 | |
| Amniox Medical, INC. | $91.94 | 2020 | |
| Biocomposites INC | $63.64 | 2019 | |
| Nevro Corp. | $57.61 | 2019 | |
| Organogenesis INC. | $42.62 | 2021 | |
| Coastal Medical Technologies LLC | $37.48 | 2023 | |
| Next Science LLC | $36.25 | 2023 | Xperience, Surgx, Blastx |
| Wright Medical Technology, INC. | $35.83 | 2020 | |
| Celularity INC. | $35.53 | 2020 | |
| Kci USA, INC. | $34.35 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $24.07 | 2020 | |
| Smith+Nephew, INC. | $21.84 | 2022 | |
| Biotissue Holdings INC. | $20.89 | 2020 | |
| Bioventus LLC | $17.89 | 2022 | |
| Averitas Pharma INC. | $16.27 | 2023 | Qutenza |
| Cashflow Solutions, LLC | $15.00 | 2023 | Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White |
| Convatec INC. | $14.60 | 2024 | |
| Paratek Pharmaceuticals, INC. | $12.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bret Musser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.